The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
Abstract
Objective : Low levels of testosterone in men have been shown to be associated with type 2 diabetes, visceral adiposity, dyslipidaemia and metabolic syndrome. We investigated the effect of testosterone treatment on insulin resistance and glycaemic control in hypogonadal men with type 2 diabetes. Design : This was a double-blind placebo-controlled crossover study in 24 hypogonadal men (10 treated with insulin) over the age of 30 years with type 2 diabetes. Methods : Patients were treated with i.m. testosterone 200 mg every 2 weeks or placebo for 3 months in random order, followed by a washout period of 1 month before the alternate treatment phase. The primary outcomes were changes in fasting insulin sensitivity (as measured by homeostatic model index (HOMA) in those not on insulin), fasting blood glucose and glycated haemoglobin. The secondary outcomes were changes in body composition, fasting lipids and blood pressure. Statistical analysis was performed on the delta values, with the treatment effect of placebo compared against the treatment effect of testosterone. Results : Testosterone therapy reduced the HOMA index (−1.73 ± 0.67, P = 0.02, n = 14), indicating an improved fasting insulin sensitivity. Glycated haemoglobin was also reduced (−0.37 ± 0.17%, P = 0.03), as was the fasting blood glucose (−1.58 ± 0.68 mmol/l, P = 0.03). Testosterone treatment resulted in a reduction in visceral adiposity as assessed by waist circumference (−1.63 ± 0.71 cm, P = 0.03) and waist/hip ratio (−0.03 ± 0.01, P = 0.01). Total cholesterol decreased with testosterone therapy (−0.4 ± 0.17 mmol/l, P = 0.03) but no effect on blood pressure was observed. Conclusions : Testosterone replacement therapy reduces insulin resistance and improves glycaemic control in hypogonadal men with type 2 diabetes. Improvements in glycaemic control, insulin resistance, cholesterol and visceral adiposity together represent an overall reduction in cardiovascular risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Insulin sensitivity may improve within few days, but effects on glycemic control become evident only after 3–12 months.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“and a decrease in the waist hip ratio after 3 months (31, 36) or after 6 months and 30 weeks respectively (17).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decrease in trunk fat or waist circumference was noted in a number of studies after 3 months (35, 36) with continuous decline over 24 months (32)”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“Several studies indicate that upon testosterone administration, serum glucose is reduced after 3 months in men with impaired glucose tolerance (31, 36, 43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decline in HbA1c was observed after 3 months (31, 36, 43) with further decrease after 12 months (43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“A decrease in serum proinsulin and insulin was noted after 3 months (43) or 6 months (45), and a decrease in homeostasis model assessment index of insulin resistance (HOMA-IR) after 3 months (36) or 6 months (45–47).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [36]
In the citing paper
“Certainly, testosterone replacement can improve performance, mood, and libido in men with hypogonadism (22) and augments insulin sensitivity (11,15).”
From Low testosterone levels are common and associated with insulin resistance in men with diabetes (2008) · cites this paper as [11]
In the citing paper
“T plays an important role in maintaining glycemic control [2].”
In the citing paper
“Furthermore, there is recent evidence that testosterone replacement therapy improves insulin resistance, glycemic control, cholesterol levels, and waist circumference in diabetic men with low testosterone levels (26).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
In the citing paper
“Testosterone treatment has also been shown to reduce insulin resistance in obese men (23,24), men with heart failure (25), and type 2 diabetic subjects (26).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
In the citing paper
“Two studies in type 2 diabetic men have shown an improvement in glycemic control (26,27) with testosterone replacement therapy”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [26]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Self-citationThe assessment of insulin resistance in man
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00745.x · Cited by 685
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
(1996) · PubMed · Cited by 643
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631
Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Oh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 785
Testosterone and cardiovascular disease – the controversy and the facts
Morgentaler, A., Feibus, A. H., & Baum, N. H. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.996111 · Cited by 19
Determinants of male health: the interaction of biological and social factors
de Kretser, D. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.15 · Cited by 18
Helo, S., Mahon, J., Ellen, J. H., Wiehle, R. D., Fontenot, G. K., Hsu, K., Feustel, P. J., Welliver, C., & McCullough, A. (2016) · British Journal of Urology · doi:10.1111/bju.13625 · Cited by 19
Testosterone deficiency, metabolic syndrome and diabetes mellitus
Fernández-Miró, M., Chillarón, J. J., & Pedro‐Botet, J. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.06.002 · Cited by 18
Effects of androgens on glucose metabolism
Umapathysivam, M. M., Grossmann, M., & Wittert, G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101654 · Cited by 18
Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
Deepika, F., Ballato, E., Colleluori, G., Aguirre, L. E., Chen, R., Qualls, C., Villareal, D. T., & Armamento‐Villareal, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.915309 · Cited by 19
Kamenov, Z. A. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02148.x · Cited by 17
Testosterone Deficiency, Cardiac Health, and Older Men
Hackett, G. I., Kirby, M. G., & Sinclair, A. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/143763 · Cited by 17
Dedov, I. I., Mel'nichenko, G. A., Shestakova, M. V., Rozhivanov, R. V., Терехова, А. Л., Zilov, A. V., Ladygina, D. O., & Курбатов, Д. Г. (2017) · Obesity and metabolism · doi:10.14341/omet2017483-92 · Cited by 17
Lombardi, M., Mercuro, G., Fini, M., & Rosano, G. M. C. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00834.x · Cited by 17
Xia, J.-W., Tan, S., Zhang, X., Jun, T., Sun, X., & Ling, W. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12291 · Cited by 17
Aydoğdu, A., Bolu, E., Sönmez, A., Taşçı, İ., Haymana, C., Acar, R., Meriç, C., Taşlıpınar, A., Özgürtaş, T., & Azal, Ö. (2012) · Clinical Endocrinology · doi:10.1111/cen.12135 · Cited by 17
Testosterone Supplementation Therapy in the Treatment of Patients with Metabolic Syndrome
Kovac, J. R., Pastuszak, A. W., Lamb, D. J., & Lipshultz, L. I. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2843 · Cited by 18
Theodoraki, A., & Bouloux, P.-M. G. (2009) · Menopause international · doi:10.1258/mi.2009.009025 · Cited by 17
Sönmez, A., Haymana, C., Aydoğdu, A., Tapan, S., Başaran, Y., Meriç, C., Başköy, K., Dinç, M., Yazıcı, M., Taşlıpınar, A., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0125 · Cited by 17
Sexual Function in Men with Metabolic Syndrome
Lee, R. K., Chughtai, B. I., Te, A. E., & Kaplan, S. A. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.008 · Cited by 18
Blick, G. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.03.2639 · Cited by 17
Umoh, U., Davies, C. J., & Adeleye, J. (2010) · Cited by 17
Liu, H., Guo, D., Ruzi, A., Chen, Y., Pan, T., Yang, F., Li, J., Xu, K., Zhou, T., Qin, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179353 · Cited by 17
Exercise to Reduce Obesity in SCI
Nash, M. S., & Gater, D. R. (2007) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1204-76 · Cited by 17
Adrenal steroids and the metabolic syndrome
Thomson, S. P., Stump, C. S., Kurukulasuriya, L. R., & Sowers, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0093-4 · Cited by 17
Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
Rabiee, A., Dwyer, A. A., Caronia, L. M., Hayes, F. J., Yialamas, M. A., Andersen, D. K., Thomas, B. J., Torriani, M., & Elahi, D. (2010) · Endocrine Research · doi:10.3109/07435801003705601 · Cited by 17
Sepu, N., Adeleye, J. O., & Kuti, M. A. (2021) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.11.014 · Cited by 16
Testicular Dysfunction in Systemic Diseases
Sartorius, G. A., & Handelsman, D. J. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_18 · Cited by 16
The role of the urologist in the prevention and early detection of cardiovascular disease
Yassin, A. A., Saad, F., Haider, A., & Gooren, L. J. (2011) · Arab Journal of Urology · doi:10.1016/j.aju.2011.03.014 · Cited by 16
Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus
Ugwu, T. E., Ikem, R. T., Kolawole, B. A., & Ezeani, I. U. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.190554 · Cited by 16
Lim, C. A.-R., Nightingale, T. E., Elliott, S., & Krassioukov, A. V. (2019) · Spinal Cord · doi:10.1038/s41393-019-0404-z · Cited by 16
Linnér, C., Svartberg, J. B., Giwercman, A., & Giwercman, Y. L. (2013) · The Aging Male · doi:10.3109/13685538.2013.772134 · Cited by 16
Samaras, N., Samaras, D., Lang, P. O., Forster, A., Pichard, C., Frangos, E., & Meyer, P. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.11.009 · Cited by 16
Testosterone and cardiovascular risk in patients with erectile dysfunction.
Corona, G., Rastrelli, G., Balercia, G., Sforza, A., Forti, G., & Maggi, M. (2012) · PubMed · doi:10.3275/8063 · Cited by 16
Donner, D. G., Elliott, G. E., Beck, B. R., Bulmer, A. C., Lam, A. K.-Y., Headrick, J. P., & Toit, E. F. D. (2015) · Endocrinology · doi:10.1210/en.2015-1603 · Cited by 16
Aversa, A., Bruzziches, R., Greco, E. A., Pili, M., Francomano, D., & Spera, G. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502389 · Cited by 16
Endogenous testosterone levels and cardiovascular disease in healthy men
Channer, K. S. (2011) · Heart · doi:10.1136/hrt.2010.217414 · Cited by 16
Self-citationDegechisa, S. T., Kinde, S., Dedefo, G., Mudi, K., & Tarekegn, G. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1541668 · Cited by 15
Liu, D., Li, Y., Ji, N., Xia, W., Zhang, B., & Feng, X. (2024) · BMC Public Health · doi:10.1186/s12889-024-19202-5 · Cited by 15
Yassin, D., Yassin, A. A., & Hammerer, P. G. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12378 · Cited by 15
Gawałek, M., & Sliwowska, J. H. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.04.001 · Cited by 15
Dedov, I. I., Mel'nichenko, G. A., Rozhivanov, R. V., & Курбатов, Д. Г. (2015) · Problems of Endocrinology · doi:10.14341/probl201561560-71 · Cited by 15
Huang, G. T.-W., Pencina, K. M., Li, Z., Apovian, C. M., Travison, T. G., Storer, T. W., Gagliano‐Jucá, T., Basaria, S. S., & Bhasin, S. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab007 · Cited by 17
Blick, G., Khera, M., Bhattacharya, R. K., Kushner, H., & Miner, M. M. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.03.2638 · Cited by 15
Hypogonadism in men with type 2 diabetes
Jones, T. H. (2007) · Practical Diabetes · doi:10.1002/pdi.1117 · Cited by 15
Self-citationSalah, M., Ismail, K. A., & Khadrawy, S. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06858-0 · Cited by 14
Mu, Y., Ruiping, S., Zhang, H., Dong, B., Huang, C., Lin, W., Li, D., & Li, X. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00512.x · Cited by 14
Men's Health, Low Testosterone, and Diabetes Individualized
Rice, D., Brannigan, R. E., Campbell, R. K., Fine, S. R., Jack, L., Nelson, J. B., & Regan-Klich, J. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708327143 · Cited by 14
Testosterone Deficiency in Men
(2008) · Oxford University Press eBooks · doi:10.1093/med/9780199545131.001.0001 · Cited by 14
Testosterone replacement therapy
Seal, L. (2009) · Medicine · doi:10.1016/j.mpmed.2009.06.002 · Cited by 14
Hackett, G. I. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02922.x · Cited by 13
Testosterone, obesity, diabetes and the metabolic syndrome
Jones, T. H., & Channer, K. S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.012 · Cited by 13
Self-citationIn Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction
Aoun, F. Y., Chemaly, A. K., Albisinni, S., Zanaty, M., & Roumeguère, T. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.1 · Cited by 13
Pelletier, R. ‐., Akpovi, C. D., Chen, L., & Vitale, M. L. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00215.2017 · Cited by 13
Paruk, I. M., Pirie, F. J., Nkwanyana, N. M., & Motala, A. A. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v109i12.013893 · Cited by 13
Male hypogonadism: The unrecognized cardiovascular risk factor
Potenza, M. V., & Shimshi, M. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.01.011 · Cited by 13
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Serum Resistin and Polymorphisms of Androgen Receptor CAGn and GGNn and Aromatase TTTAn
Hernández, A. G., de León, A. C., Coello, S. D., González, D. A., Pérez, M. D. C. R., Díaz, B. B., Aguirre‐Jaime, A., & Díaz-Chico, B. N. (2008) · Obesity · doi:10.1038/oby.2008.289 · Cited by 13
Zolla, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112730 · Cited by 12
Best, J. C., Gonzalez, D. C., Masterson, T. A., Blachman-Braun, R., Pai, R., & Ramasamy, R. (2020) · Canadian Urological Association Journal · doi:10.5489/cuaj.6651 · Cited by 12
Park, H. C., Kim, H., Lee, H. S., & Lee, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-87220-z · Cited by 12
Androgens and cardiovascular disease: Gender-related differences
Spoletini, I., Caprio, M., Vitale, C., & Rosano, G. M. C. (2013) · Menopause international · doi:10.1177/1754045313487720 · Cited by 12
Prevalence of erectile dysfunction among Saudi type 2 diabetic patients.
Hassan, A., Aburisheh, K. H., Sheikh, T., Meo, S. A., Ahmed, N., & Sharqawi, A. (2014) · PubMed · Cited by 12
Oni, O. A., Sharma, R., Chen, G., Sharma, M., Gupta, K., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Cherian, G., et al. (2017) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2017.05.003 · Cited by 12
Kim, N. H., Jung, Y. S., Park, J. H., Park, D. I., & Sohn, C. I. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001086 · Cited by 12
Strategies in the treatment of HIV-1-associated adipose redistribution syndromes
Gutiérrez, M. D. M., Mateo, G. M., & Domingo, P. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1871 · Cited by 12
Čulić, V., & Bušić, Ž. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.220 · Cited by 11
Reddy, K., & Yadav, S. (2021) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_887_20 · Cited by 11
Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus
Arafa, M. M., Zohdy, W., Aboulsoud, S. H., & Shamloul, R. M. (2011) · Andrologia · doi:10.1111/j.1439-0272.2011.01262.x · Cited by 11
Chillarón, J. J., Fernández-Miró, M., Albareda, M., Fontserè, S., Colom, C., Vila, L. I. S., Pedro‐Botet, J., & Roux, J. A. F. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0195 · Cited by 11
Doulamis, I. P., Tzani, A. I., Konstantopoulos, P. S., Daskalopoulou, A., Spinos, T., Bletsa, E., Mitsopoulou, D., Spinou, Μ., Brinia, M. E., Palaiopanos, K., et al. (2019) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2018-0118 · Cited by 11
The differences of sarcopenia-related phenotypes: effects of gender and population
Zhong, K., Lei, S., Yang, F., Chen, X., Tan, L., Zhu, X.-Z., Tian, Q., & Deng, H. (2011) · European Review of Aging and Physical Activity · doi:10.1007/s11556-011-0082-0 · Cited by 11
Androgen receptor agonism promotes an osteogenic gene program in preadipocytes
Hartig, S. M., Feng, Q. F., Ochsner, S. A., Xiao, R., McKenna, N. J., McGuire, S. E., & He, B. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.078 · Cited by 11
Jabaloyas, J. M. M., Zaragoza, A., Cortés, C., Zaragozá, J. A. Q., Salom, M. G., & Nuez, P. C. (2008) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(08)73895-6 · Cited by 11
Intapad, S., Dasinger, J., Fahling, J., Backstrom, M. A., & Alexander, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187843 · Cited by 9
Diabetes surpasses obesity as a risk factor for low serum testosterone level
Khalil, S. H. A., Dandona, P., Osman, N. A., Assaad, R. S., Zaitoon, B. T. A., Almas, A. A., & Amin, N. G. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01373-1 · Cited by 11
Metabolic Syndrome, Obesity Paradox and Testosterone Level
Emanuele, V. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000172 · Cited by 10
Yuen, F., Thirumalai, A., Fernando, F., Swerdloff, R. S., Liu, P. Y., Pak, Y., Hull, L., Bross, R., Blithe, D., Long, J. E., et al. (2021) · Andrology · doi:10.1111/andr.13025 · Cited by 10
Zyoud, S. H. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00497-4 · Cited by 10
JENKINS, C., Rittel, A. G., Sturdivant, R. X., Wan, J., CLERC, P. G., Manning, E., Jenkins, L. M., Wardian, J., & Graybill, S. D. (2021) · Andrology · doi:10.1111/andr.12990 · Cited by 10
Effects of short-term sex steroid suppression on dietary fat storage patterns in healthy males
Rynders, C. A., Schmidt, S. L., Bergouignan, A., Horton, T. J., & Bessesen, D. H. (2018) · Physiological Reports · doi:10.14814/phy2.13533 · Cited by 9
Weng, C., Shao, Z., Xiao, M., Song, M., Zhao, Y., Li, A., Pang, Y., Huang, T., Yu, C., Lv, J., et al. (2024) · Liver International · doi:10.1111/liv.15866 · Cited by 9
The Impact of Testosterone on Erectile Function
Schardein, J. N., & Hotaling, J. M. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0033 · Cited by 10
de Pedro‐Cuesta, J., Martínez‐Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. J. G., Almazán‐Isla, J., Ruiz-Tovar, M., Medrano, M.-J., Avellanal, F., Calero, O., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150884 · Cited by 9
Tirabassi, G., Muti, N. D., Buldreghini, E., Lenzi, A., & Balercia, G. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.02.016 · Cited by 9
Ukkola, O. H., Huttunen, T., Puurunen, V.-P., Piira, O.-P., Niva, J., Lepojärvi, S., Tulppo, M. P., & Huikuri, H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.711951 · Cited by 9
Die Therapie des Hypogonadismus des Mannes
Zitzmann, M. (2008) · Der Internist · doi:10.1007/s00108-008-2108-x · Cited by 9
Testosterone Deficiency Associated with Poor Glycemic Control in Korean Male Diabetics
Kim, J., Kim, B. S., Jeon, J. Y., Choi, Y. J., & Chung, Y. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.300 · Cited by 9
Investigating the basis of sexual dysfunction during late-onset hypogonadism
Tharakan, T., Miah, S., Jayasena, C. N., & Minhas, S. (2019) · F1000Research · doi:10.12688/f1000research.16561.1 · Cited by 9
Kreiberg, M., Jørgensen, N., Juul, A., Lauritsen, J., Oturai, P., Helge, J. W., Christensen, J. F., Aksglæde, L., Schauer, T., Wagner, T., et al. (2022) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2022.04.017 · Cited by 9
Clinical awareness and diagnosis of male hypogonadism
Jones, T. H. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.014 · Cited by 9
Self-citationWang, C., Yang, X., Zhang, H., Zhang, Y., Tao, J., Jiang, X., & Wu, C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1225931 · Cited by 8
Zhang, L., Cai, Y., Wei, S., Ling, Y., Zhu, L., Li, D., & Cai, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122125 · Cited by 8
Pathophysiology of Type 2 Diabetes
Kesavadev, J., Jawad, F., Deeb, A., Coetzee, A., Ansari, M., Shrestha, D., Somasundaram, N. P., & Kalra, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_9 · Cited by 9
Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
Kim, J. W., & Moon, D. G. (2011) · Korean journal of urology · doi:10.4111/kju.2011.52.11.725 · Cited by 8
Late-onset male hypogonadism and testosterone replacement therapy in primary care.
Brunton, S., & D, R. S. M. (2010) · PubMed · Cited by 8
The treatment of late-onset hypogonadism
Üçer, O., & Gumus, B. (2014) · Urology Research and Practice · doi:10.5152/tud.2013.97752 · Cited by 8
Windows of opportunity: a holistic approach to men's health*
Holden, C. A., Allan, C. A., & McLachlan, R. I. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03708.x · Cited by 8
Himoto, T., Fujita, K., Sakamoto, T., Nomura, T., Morishita, A., Yoneyama, H., Haba, R., & Masaki, T. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-30 · Cited by 8
The effects of testosterone replacement therapy on the prostate: a clinical perspective
Miah, S., Tharakan, T., Gallagher, K. A., Shah, T. T., Winkler, M. H., Jayasena, C. N., Ahmed, H. U., & Minhas, S. (2019) · F1000Research · doi:10.12688/f1000research.16497.1 · Cited by 8
Raza, M. T., Sharif, S., Khan, Z. A., Naz, S., Mushtaq, S., & Umer, A. (2019) · Cureus · doi:10.7759/cureus.6500 · Cited by 8
Plasma Metabonomics in Insulin-Resistant Hypogonadic Patients Induced by Testosterone Treatment
Zolla, L., Grande, G., & Milardi, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147754 · Cited by 8
Ogbera, A. O. (2011) · PubMed · Cited by 8
Pattern of male sex hormones in type 2 diabetic patients in Nnewi, South Eastern Nigeria
Onah, C. E. (2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1046570 · Cited by 8
Metadata
- Authors
- Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H.
- Affiliations
- Barnsley Hospital NHS Foundation Trust (GB)
- National Health Service (GB)
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06
- Volume
- 154
- Issue
- 6
- Pages
- 899-906
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142908894
- Cited by
- 791
- References
- 45
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 13 · 2023: 23 · 2022: 27 · 2021: 34 · 2020: 27 · 2019: 32 · 2018: 38 · 2017: 39 · 2016: 38 · 2015: 55 · 2014: 61 · 2013: 55 · 2012: 43
- FWCI
- 36.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone replacement therapy, hypogonadism, type 2 diabetes, insulin resistance, glycemic control, visceral fat, hypercholesterolemia, dyslipidemia, HbA1c, waist circumference, cardiovascular risk
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Humans, Hypercholesterolemia, Hypogonadism, Insulin Resistance, Male, Middle Aged, Testosterone, Cross-Over Studies, Hormone Replacement Therapy, Abdominal Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
